INGENITO, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 171
NA - Nord America 132
AS - Asia 74
AF - Africa 8
OC - Oceania 3
Totale 388
Nazione #
IT - Italia 148
US - Stati Uniti d'America 131
SG - Singapore 34
HK - Hong Kong 22
CI - Costa d'Avorio 8
CN - Cina 7
IN - India 7
FI - Finlandia 6
FR - Francia 5
SE - Svezia 3
AU - Australia 2
BE - Belgio 2
DE - Germania 2
GB - Regno Unito 2
PK - Pakistan 2
RU - Federazione Russa 2
CA - Canada 1
IE - Irlanda 1
NP - Nepal 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 388
Città #
Rome 41
Singapore 29
Hong Kong 22
Santa Clara 20
Ashburn 19
Chandler 18
Napoli 16
Naples 14
San Giorgio del Sannio 13
Lawrence 7
Millbury 7
Pune 6
Helsinki 5
San Felice A Cancello 5
Avellino 4
Boston 4
Des Moines 4
Castries 3
Fairfield 3
Fisciano 3
Göteborg 3
Milan 3
Woodbridge 3
Afragola 2
Columbus 2
Ercolano 2
Falkenstein 2
Formia 2
Pellezzano 2
Phoenix 2
Sargodha 2
Sennori 2
Swindon 2
Verona 2
Wilmington 2
Auckland 1
Bologna 1
Brusciano 1
Castelvetere sul Calore 1
Chongqing 1
Dallas 1
Dublin 1
Ghent 1
Gurgaon 1
Kathmandu 1
Kraainem 1
Lappeenranta 1
Lille 1
Los Angeles 1
Noble Park 1
Norwalk 1
Orta di Atella 1
Quarto 1
Redwood City 1
Serio 1
Shanghai 1
Shenzhen 1
Somma Vesuviana 1
Toronto 1
Washington 1
Totale 301
Nome #
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 75
MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment 59
Potential and challenges of aptamers as specific carriers of therapeutic oligonucleotides for precision medicine in cancer 51
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 47
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications 44
Modulating the crosstalk between the tumor and the microenvironment using sirna: A flexible strategy for breast cancer treatment 44
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer 42
Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study 31
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 29
Totale 422
Categoria #
all - tutte 1.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 4 0 1 3 0 0
2020/202142 3 0 4 0 0 0 6 8 8 5 5 3
2021/202298 36 1 1 0 11 15 0 1 2 7 7 17
2022/202351 7 0 1 2 8 4 0 10 11 2 5 1
2023/202496 19 3 7 10 1 19 0 12 3 2 14 6
2024/2025114 8 13 6 3 17 34 33 0 0 0 0 0
Totale 422